Starling Oncology, Inc. Deferred Tax Liabilities, Leasing Arrangements
Starling Oncology, Inc. (STLN) had Deferred Tax Liabilities, Leasing Arrangements of $6.32 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesLeasingArrangements · last filed 2026-03-12
- 2025-12-31: Deferred Tax Liabilities, Leasing Arrangements $6.32M.
- 2024-12-31: Deferred Tax Liabilities, Leasing Arrangements $7.29M.
- 2023-12-31: Deferred Tax Liabilities, Leasing Arrangements $8.36M.
- 2022-12-31: Deferred Tax Liabilities, Leasing Arrangements $7.01M.
| Period end | Deferred Tax Liabilities, Leasing Arrangements |
|---|---|
| 2025-12-31 | $6.32M 10-K · filed 2026-03-12 |
| 2024-12-31 | $7.29M 10-K · filed 2026-03-12 |
| 2023-12-31 | $8.36M 10-K · filed 2025-03-26 |
| 2022-12-31 | $7.01M 10-K · filed 2024-03-28 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 |